Trial Profile
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs CD4 IgG (Primary)
- Indications Acquired immunodeficiency syndrome; HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 05 Nov 2010 New trial record.